Newsletter | May 21, 2025

05.21.25 -- Track Your Trial's Carbon Footprint With This Sustainability Calculator

SPONSOR

A Full-Service Solution Partner Disrupting the Outsourcing Paradigm

inSeption Group offers a full-service solution designed to disrupt the current outsourcing paradigm, resurrecting a common-sense approach to rebuild business trust and confidence in a client’s selected vendor. Primarily focused on oncology, hematology, neurodegenerative disorders, and rare/orphan disease indications, with a specialization in cell and gene therapy, inSeption has been a solution for its’ clients who have experienced the progressive degradation of today’s outsourcing options. Contact them.

DECENTRALIZED TRIALS

7 Steps To Manage Local HCPs In A Decentralized Trial

Here’s a template you can use for a multi-step process to create a centralized system to verify the credentials, licenses, and professional standing of all local healthcare professionals (HCPs) participating in a DCT.

Inspection Readiness For Decentralized Trials

Decentralized Clinical Trials (DCTs) enhance research inclusivity by minimizing logistical barriers such as travel, scheduling conflicts, and costs, making participation more accessible.

Modernizing Research Through New Tech, Contracting, And Pricing

Meet the FDA's guidance on modernizing your clinical trials with a single-codebase solution that streamlines data capture, reduces delays, and simplifies compliance.

SPONSOR

Webinar: How Sponsors can leverage site technology to standardize quality and improve site performance

With Central eSource, sponsors define a standard electronic source template, pre-map it to the eCRF, and send it to sites, where it can be configured locally to reflect their SOPs. Learn how sponsors can leverage the electronic source trend to accelerate site startup, standardize data quality at the point of capture, accelerate EDC entry, and enable true centralized remote monitoring.

TRIAL MANAGEMENT

Track Your Trial's Carbon Footprint With This Sustainability Calculator

Pistoia Alliance Portfolio Lead Thierry Escudier discusses the latest updates to the Clinical Trial Carbon Calculator.

A Dip In NAS Launches Annual Review 2025 Supplement

Even though new active substance (NAS) launches declined 11% in 2024, this still represented the fourth-highest total of newcomers to the pharma runway recorded and predictions remain good for 2025.

Strategies For Biomarker Development And Early Phase Clinical Studies

Companion diagnostics (CDx) are crucial for personalized medicine to enable precise patient selection for therapies. Explore biomarker development strategies and early-phase study considerations.

Radiation Therapy Quality Assurance In Clinical Trials

Here, the authors describe the crucial role of radiation therapy in oncology trials and how a robust quality management program can enhance treatment outcomes and research efficacy.

Central IRB Services

BRANY IRB provides pharma, biotech and medical device companies with central irb services that combine our service-first philosophy, our expertise and a proven, efficient process.

CHOOSE YOUR OWN ADVENTURE

You're receiving the Wednesday edition of the Clinical Leader newsletter, focusing on Decentralized Trials and Trial Management. To make changes to your newsletter selections, update your topic preferences.

  • Clinical Sites | Patient Centricity | Patient Recruitment (Monday)
  • Clinical Trial Technology (Tuesday)
  • Decentralized Trials | Trial Management (Wednesday)
  • Outsourcing Models | Regulatory & Compliance (Thursday)
  • Clinical Data Management & Analytics | Trial Monitoring (Friday)

Learn more about our personalized newsletters here.

Connect With Clinical Leader: